American Registry v. Castle Connolly: Dismissed With Prejudice After 295 Days
American Registry, LLC asserted US7386800B2 — covering personalized, customized achievement recognition items — against Castle Connolly Medical Ltd. in Florida’s Southern District. The parties reached an amicable resolution and filed a stipulated dismissal with prejudice, closing the case in under ten months.
Stipulated exit in the achievement recognition IP space
On April 13, 2023, American Registry, LLC filed suit against Castle Connolly Medical Ltd. in the U.S. District Court for the Southern District of Florida (Case No. 9:23-cv-80654), asserting infringement of U.S. Patent No. 7,386,800 — a patent directed to personalized, customized achievement recognition items. Castle Connolly is well known as a publisher of physician-rating directories and recognition programs, making it a commercially logical target for this assertion.
The case closed on February 2, 2024, after the parties filed a Stipulated Dismissal with Prejudice on February 1, 2024. Under Eleventh Circuit precedent — specifically Anago Franchising, Inc. v. Shaz, LLC, 677 F.3d 1272 (11th Cir. 2012) — a parties’ stipulation of dismissal is self-executing and requires no affirmative court order. Chief Judge Middlebrooks directed the clerk to close the case and deny all pending motions as moot.
At 295 days, the resolution is relatively swift for district court patent litigation, suggesting the parties likely reached a private settlement — though the public record is silent on financial terms, licensing arrangements, or any admission of liability. The ‘with prejudice’ designation forecloses any future refiling of these specific claims by American Registry against Castle Connolly, providing the defendant with a permanent bar.
Filing to dismissal in 295 days
295 days from filing to stipulated dismissal — resolved faster than most district court patent cases
Stipulated dismissal with prejudice — what the self-executing order means
Stipulated dismissal: no court order required
Under the Eleventh Circuit’s Anago Franchising rule, a stipulation of dismissal signed by all parties is self-executing — it takes effect the moment it is filed, without requiring a judge’s signature. This means the case was effectively resolved on February 1, 2024, the filing date. Judge Middlebrooks’ order was administrative, directing the clerk to formally close the docket and moot pending motions.
Anago Franchising doctrineWith prejudice: a permanent bar on refiling
Dismissal with prejudice is a final adjudication on the merits for res judicata purposes. American Registry cannot refile the same patent claims (US7386800B2) against Castle Connolly in any subsequent action. This gives Castle Connolly permanent legal protection from this specific assertion. A dismissal without prejudice would have preserved plaintiff’s right to refile; the with-prejudice designation here is a meaningful concession by the plaintiff.
Res judicata effect confirmedPrivate terms likely underlie the stipulation
Stipulated dismissals with prejudice at this stage of litigation — before trial, but after substantial docketing activity (DE 83 indicates significant case development) — typically signal a negotiated resolution. Whether that resolution involved a licensing fee, a cross-license, a covenant not to sue, or a payment in exchange for abandonment is not disclosed in the public record. The commercial relationship between a recognition-IP holder and a physician-directory publisher suggests licensing was plausible.
Settlement probable, terms privatePatent US7386800B2 and the recognition-items market
US7386800B2 covers personalized, customized achievement recognition items — a category spanning plaques, seals, certificates, and branded recognition products. Castle Connolly’s core business of physician recognition and directory listing overlaps directly with this space. The decision to settle rather than challenge the patent’s validity may reflect either the strength of the claims or a pragmatic cost-benefit analysis on both sides.
Recognition-items patent spaceFull party and counsel information
| Role | Nom | Type | Détail |
|---|---|---|---|
| Demandeur | American Registry, LLC | Entreprise | IP holding and recognition services company — holder of US7386800B2Search in Eureka ↗ |
| Défendeur | Castle Connolly Medical Ltd. | Entreprise | Castle Connolly Medical Ltd. — physician-rating and medical achievement recognition publisherSearch in Eureka ↗ |
| Plaintiff counsel | Adam Jason Steinberg | Attorney | Counsel for American Registry, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Jonathan Ray Woodard | Attorney | Counsel for American Registry, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Meredith Frank Mendez | Attorney | Counsel for American Registry, LLCSearch in Eureka ↗ |
| Plaintiff counsel | W. John Eagan | Attorney | Counsel for American Registry, LLCSearch in Eureka ↗ |
| Defendant counsel | Guy Ruttenberg | Attorney | Counsel for Castle Connolly Medical Ltd.Search in Eureka ↗ |
| Defendant counsel | Thomas E. Scott Jr. | Attorney | Counsel for Castle Connolly Medical Ltd.Search in Eureka ↗ |
| Presiding judge | Judge Donald M. Middlebrooks | Juge en chef | Florida Southern District Court — Chief JudgeSearch in Eureka ↗ |
Stipulation of dismissal — official text
The court’s order is administrative rather than substantive — it records a self-executing stipulation filed by the parties and directs clerk closure. No claim construction, no findings of infringement or validity, and no damages determination appear in the record. The with-prejudice designation is the legally operative outcome: it permanently extinguishes American Registry’s right to reassert US7386800B2 against Castle Connolly, but leaves the patent fully alive for enforcement against all other parties.
US7386800B2 — Personalized Achievement Recognition Items
U.S. Patent No. 7,386,800, filed under application number US10/721045, covers systems and methods for creating personalized, customized achievement recognition items — a category that encompasses branded certificates, plaques, seals, and similar recognition artefacts tied to individual or institutional accomplishment. The patent sits at the intersection of publishing, credentialing, and branded recognition services, a space that has grown significantly with digital and hybrid recognition programs. Its issuance reflects protectable innovation in the customisation and delivery workflow for such items.
The patent’s commercial relevance is clear in this litigation: Castle Connolly’s physician-recognition and directory business maps directly onto the claim space. Any organisation that generates, sells, or facilitates personalized recognition items — whether in medical, academic, professional, or consumer contexts — should assess its exposure. The absence of a public validity challenge in this case means the patent’s claims remain intact and available for further assertion against third parties operating in adjacent product categories.
Should your team run an FTO against US7386800B2?
If your organisation produces, licenses, or facilitates personalised achievement or recognition items — physician awards, professional certifications, branded plaques, digital seals, or similar — US7386800B2 is a live enforcement risk. American Registry’s willingness to litigate against Castle Connolly, a prominent and legally sophisticated defendant, demonstrates that the patent holder actively monitors competitive use of this technology and is prepared to pursue infringement claims in federal court.
PatSnap Eureka’s FTO Search Agent can map your product workflows against the claims of US7386800B2 and surface related continuations or family members that may extend the coverage landscape. Setting a claim-monitoring alert on this patent and its assignee ensures your team receives real-time signals if new assertions are filed or if continuation applications introduce broader claims — allowing you to respond proactively rather than reactively.
Run a freedom-to-operate analysis on US7386800B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent infringement cases in the recognition and credentialing IP space
PatSnap Eureka tracks related litigation across truck body equipment, vehicle accessories, and comparable infringement actions in the Georgia district system.
What this case signals for the achievement recognition IP landscape
A swift, prejudicial exit suggests real commercial stakes — and that US7386800B2 carries sufficient enforceability to prompt settlement.
US7386800B2 has demonstrated enforcement credibility
The fact that Castle Connolly — a well-resourced publisher with specialist IP counsel — chose stipulated dismissal with prejudice rather than challenging validity or non-infringement suggests the patent withstood initial scrutiny. Any company operating in the personalized recognition or achievement certification space should treat this patent as an active enforcement risk.
Speed of resolution limits public precedent but protects both parties
No claim construction, no invalidity ruling, and no infringement finding entered the public record. This preserves American Registry’s ability to assert the patent against other defendants on the same terms, while giving Castle Connolly a clean exit. Competitors cannot rely on this dismissal as a validity challenge precedent.
American v Castle — key questions answered
The case was dismissed with prejudice on February 2, 2024, following a stipulated dismissal filed by both parties on February 1, 2024. No court order was required under Eleventh Circuit precedent (Anago Franchising). American Registry cannot refile the same claims against Castle Connolly.
American Registry asserted U.S. Patent No. 7,386,800 (US7386800B2), filed under application number US10/721045. The patent covers personalized, customized achievement recognition items. It was the sole patent asserted in the complaint.
Dismissal with prejudice is a final, on-the-merits termination. The plaintiff cannot refile the same claims against the same defendant in any subsequent action. It functions as res judicata. However, it does not affect the patent’s validity or the plaintiff’s right to assert the patent against different defendants.
The public record does not disclose the reasons for early resolution. At 295 days, the timeline is consistent with a negotiated private settlement — which may have involved a licence, a covenant not to sue, or a financial payment. The commercial overlap between a recognition-IP holder and a physician-directory publisher suggests licensing was a plausible outcome.
No. The dismissal only protects Castle Connolly. US7386800B2 remains a live, enforceable patent. American Registry retains full rights to assert it against any other party operating in the personalized achievement recognition space. Competitors cannot rely on this case as a validity or non-infringement shield.
PatSnap Eureka searches patents and litigation data to answer instantly.